Open Access

REVIEW

Durability and retreatment rates of minimal invasive treatments of benign prostatic hyperplasia: a cross-analysis of the literature

Bob Djavan¹, Elisabeth Eckersberger¹, Markus Johannes Handl², Roland Brandner¹, Helen Sadri¹, Herbert Lepor¹

1 Department of Urology, New York University Hospital, New York, New York, USA
2 Department of Urology, University of Vienna, Vienna, Austria
Address correspondence to Dr. Bob Djavan, Department of Urology, New York University School of Medicine, 150 East 32^nd Street, New York, New York 10016 USA

Canadian Journal of Urology 2010, 17(4), 5249-5254.

Abstract

Background: Transurethral resection of the prostate (TURP) has been the gold standard of the treatment of benign prostatic hyperplasia (BPH). In recent years there has been a significant shift in the treatment of BPH and guidelines emphasize minimally invasive surgery as a new treatment option. Minimal invasive technologies (MITs), such as transurethral microwave thermotherapy (TUMT), laser ablations, transurethral needle ablation (TUNA) have emerged as an alternative to the TURP.
Objectives: To assess the retreatment rates of the most commonly used minimal invasive techniques.
Search strategy: Durability articles were selected by using defined search terms using PubMed as search engine.
Results: Comparing to the overall retreatment rates of MITs the results show that TUMT, holmium laser enucleation of the prostate (HoLEP) and contact laser vaporization (CLV) are among the treatments with the lowest retreatment rates. Studies show no significant differences in retreatment rates between TUMT and TURP.
Conclusion: A review of the current literature, long term results and retreatment rates of MITs shows large variability in outcomes and retreatment rates. The true definition of a MIT remains unclear. High energy TUMT deserves reconsideration in clinical practices, due to low retreatment rates and the low need of anesthetics.

---

Keywords

---